Half-year report · HY
9158.TEDINET S100X3FV
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.3bn | 2025-04-01 → 2025-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥47.0bn | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥21.6bn | 2024-04-01 → 2024-09-30 | Cons. | Revenue IFRS |
| Operating income | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥1.4bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥5.2bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥3.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥612m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥3.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥566m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss IFRS |
| Total assets | ¥94.1bn | at 2025-09-30 | Cons. | Assets IFRS |
| Total assets | ¥85.2bn | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥70.2bn | at 2024-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥63.4bn | at 2025-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥54.9bn | at 2025-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥30.7bn | at 2025-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥30.3bn | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥28.5bn | at 2024-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥28.0bn | at 2024-03-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥30.2bn | at 2025-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥29.7bn | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥27.9bn | at 2024-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥13.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥7.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥13.2bn | at 2024-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥8.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥2.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥1.9bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥3.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥4.5bn | 2024-04-01 → 2025-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥6.9bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥7.6bn | 2024-04-01 → 2025-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥5.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥20.89 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥106.81 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥68.51 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥20.89 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥106.81 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥68.51 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 32.0% | at 2025-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 34.8% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 39.8% | at 2024-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 52
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | −¥10m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥226m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥226m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥454m |
| Hospicereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥7.9bn |
| Hospicereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥7.9bn |
| Hospicereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥139m |
| In Home Nursingreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥6.5bn |
| In Home Nursingreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥6.5bn |
| In Home Nursingreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥3m |
| In Home Nursingreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥657m |
| Management Supportreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥8.2bn |
| Management Supportreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥8.0bn |
| Management Supportreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥223m |
| Management Supportreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.5bn |
| Medical Care Residencereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.8bn |
| Medical Care Residencereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.8bn |
| Medical Care Residencereportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥96m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥26.5bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥26.3bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥226m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥26.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥226m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥83m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥83m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥55m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥157m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥157m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥439m |
| Hospicereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥6.7bn |
| Hospicereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥6.7bn |
| Hospicereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥690m |
| In Home Nursingreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥6.1bn |
| In Home Nursingreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥6.1bn |
| In Home Nursingreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥540m |
| Management Supportreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥8.9bn |
| Management Supportreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥8.7bn |
| Management Supportreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥157m |
| Management Supportreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.2bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥21.7bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥21.5bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥157m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥3.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥21.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥21.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥157m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥3.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 851
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | InterimInstant_No2MajorShareholdersMember | 1820000 | |
| Shareholding ratio | InterimInstant_No2MajorShareholdersMember | 0.0621 | |
| Number of shares held | InterimInstant_No3MajorShareholdersMember | 1292000 | |
| Shareholding ratio | InterimInstant_No3MajorShareholdersMember | 0.0441 | |
| Number of shares held | InterimInstant_No4MajorShareholdersMember | 870000 | |
| Shareholding ratio | InterimInstant_No4MajorShareholdersMember | 0.0297 | |
| Number of shares held | InterimInstant_No5MajorShareholdersMember | 775000 | |
| Shareholding ratio | InterimInstant_No5MajorShareholdersMember | 0.0264 | |
| Number of shares held | InterimInstant_No6MajorShareholdersMember | 488000 | |
| Shareholding ratio | InterimInstant_No6MajorShareholdersMember | 0.0166 | |
| Number of shares held | InterimInstant_No7MajorShareholdersMember | 414000 | |
| Shareholding ratio | InterimInstant_No7MajorShareholdersMember | 0.0141 | |
| Number of shares held | InterimInstant_No8MajorShareholdersMember | 383000 | |
| Shareholding ratio | InterimInstant_No8MajorShareholdersMember | 0.0131 | |
| Number of shares held | InterimInstant_No9MajorShareholdersMember | 303000 | |
| Shareholding ratio | InterimInstant_No9MajorShareholdersMember | 0.0103 | |
| Number of shares held | InterimInstant_No10MajorShareholdersMember | 250000 | |
| Shareholding ratio | InterimInstant_No10MajorShareholdersMember | 0.0085 | |
| Number of shares held | InterimInstant | 25197000 | |
| Shareholding ratio | InterimInstant | 0.8595 | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 675000 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 29310800 | |
| Number of voting rights issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 293108 | |
| Number of shares issued shares voting rights | InterimInstant_SharesLessThanOneUnitMember | 4600 | |
| Number of shares issued shares voting rights | InterimInstant | 29990400 | |
| Number of voting rights issued shares voting rights | InterimInstant | 293108 | |
| Number of shares held in own name treasury shares etc | InterimInstant_Row1Member | 675000 | |
| Number of shares held in others names treasury shares etc | InterimInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | InterimInstant_Row1Member | 675000 | |
| Shareholding ratio treasury shares etc | InterimInstant_Row1Member | 0.0225 | |
| Number of shares held in own name treasury shares etc | InterimInstant | 675000 | |
| Number of shares held in others names treasury shares etc | InterimInstant | － | |
| Total number of shares held treasury shares etc | InterimInstant | 675000 | |
| Shareholding ratio treasury shares etc | InterimInstant | 0.0225 | |
| Cash and cash equivalents IFRS | Prior1YearInstant | 7533000000 | JPY |
| Cash and cash equivalents IFRS | InterimInstant | 13324000000 | JPY |
| Trade and other receivables ca IFRS | Prior1YearInstant | 12151000000 | JPY |
| Trade and other receivables ca IFRS | InterimInstant | 12946000000 | JPY |
| Inventories ca IFRS | Prior1YearInstant | 160000000 | JPY |
| Inventories ca IFRS | InterimInstant | 182000000 | JPY |
| Other financial assets ca IFRS | Prior1YearInstant | 94000000 | JPY |
| Other financial assets ca IFRS | InterimInstant | 116000000 | JPY |
| Other current assets ca IFRS | Prior1YearInstant | 582000000 | JPY |
| Other current assets ca IFRS | InterimInstant | 693000000 | JPY |
| Current assets IFRS | Prior1YearInstant | 20520000000 | JPY |
| Current assets IFRS | InterimInstant | 27261000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |